Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CT

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for multi-slice CT.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ono Pharmaceutical Co. Ltd
• Treatments: Landiolol

Criteria

Inclusion Criteria:

1. 20-74 years old

2. Heart rate less than 90 beats/min more than 70 beats/min at entering the CT room

Exclusion Criteria:

1. Previous allergic reactions to contrast agent

2. Renal failure

3. Asthma

4. Other exclusion criteria as specified in the protocol